SO
CGON icon

STRS Ohio’s CG Oncology CGON Stock Holding History

STRS Ohio’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$447K Buy
+6,600
New +$374K ﹤0.01% 1140
2024
Q2 		– Sell
-4,100
Closed -$179K – 1977
2024
Q1 		$179K Buy
+4,100
New +$167K ﹤0.01% 1585

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

STRS Ohio's CGON Position: Q1 2026 in Review

STRS Ohio opened a new position in CG Oncology (CGON) in Q1 2026: 6,600 shares worth $447K. The stake represents ﹤0.01% of the portfolio and ranks #1140 among its holdings. This is a return to the name: STRS Ohio previously reported a position in CGON as recently as Q1 2024.

STRS Ohio first reported a position in CGON in Q1 2024 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • STRS Ohio held 6,600 shares of CG Oncology worth $447K as of Q1 2026.
  • CG Oncology was a new STRS Ohio position in Q1 2026.
  • CG Oncology made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1140 holding.
  • STRS Ohio first reported a position in CG Oncology in Q1 2024 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.